🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Ribavirin (R)

Found 87 matching trials

A Study to Evaluate the Safety and Effect of the Experimental Drugs ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Subjects With Chronic Hepatitis C

PHASE3

The purpose of this study is to evaluate the safety and antiviral activity ...

Status

Completed

Location

Multiple Locations

Start Date

2012-08

Trial ID

NCT01674725

Treatments Being Tested

ABT-450/r/ABT-267, ABT-333 Ribavirin

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Germany (LIFE-C)

N/A

The interferon-free combination regimen of paritaprevir/r - ombitasvir with...

Status

Completed

Location

Multiple Locations

Start Date

2015-12-03

Trial ID

NCT02615145

Ombitasvir/ABT-450/Ritonavir and Dasabuvir Therapy With Low Dose Ribavirin (RBV), Full Dose RBV or RBV Add-On in Treatment Naive Genotype 1a Hepatitis C Virus Infected Adults

PHASE2

To evaluate the effect of ribavirin on second phase plasma hepatitis C viru...

Status

Completed

Location

Multiple Locations

Start Date

2015-06

Trial ID

NCT02493855

Treatments Being Tested

Ombitasvir/ABT-450/Ritonavir Dasabuvir Ribavirin (RBV)

Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in Asiatic HCV Patients Resistant to Bitherapy

PHASE1

This study is designed to evaluate the safety of biological active dose of ...

Status

Unknown

Location

Kaohsiung Medical University Hospital

Start Date

2009-01

Trial ID

NCT01024894

Treatments Being Tested

Interleukin-7

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Co-Administered With Sofosbuvir With and Without Ribavirin in Treatment-Naive HCV Genotype 1-Infected Adults

PHASE3

This open-label study will evaluate the safety and efficacy of co-formulate...

Status

Completed

Location

Multiple Locations

Start Date

2015-03

Trial ID

NCT02399345

Treatments Being Tested

ombitasvir/paritaprevir/ritonavir, dasabuvir sofosbuvir (SOF)ribavirin (RBV)

Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT- 267 (ABT-450/r/ABT-267) in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus (HCV) Infection

PHASE3

This is a Phase 3, randomized, open-label, multicenter study, enrolling non...

Status

Completed

Location

Multiple Locations

Start Date

2014-01

Trial ID

NCT02023112

Treatments Being Tested

ABT-450/r/ABT-267 Ribavirin

An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients

PHASE2

To assess efficacy of telaprevir, pegylated interferon alfa-2a (Peg-IFN-alf...

Status

Terminated

Location

Alabama

Start Date

2012-02

Trial ID

NCT01467505

Treatments Being Tested

Telaprevir Ribavirin Pegylated Interferon Alfa-2a Immunosuppressant Regimen

Observational, Multi-Center Study of the Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in the Russian Federation

N/A

This study seeks to assess the effectiveness, patient reported outcomes, wo...

Status

Completed

Location

Multiple Locations

Start Date

2016-04-15

Trial ID

NCT02669940

A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/r With or Without Dasabuvir and With or Without Ribavirin in Chronic Hepatitis C Virus Genotype 1 or 4 Infected Adults With Successfully Treated Early Stage Hepatocellular Carcinoma

PHASE3

The purpose of this study is to evaluate the safety and efficacy of ombitas...

Status

Terminated

Location

Multiple Locations

Start Date

2015-07

Trial ID

NCT02504099

Treatments Being Tested

ombitasvir/paritaprevir/ritonavir and dasabuvir ombitasvir/paritaprevir/ritonavir ribavirin

This Trial Evaluates Safety, Pharmacokinetic Profile and Anti-viral Response of BI 207127 and BI 201335 for Patients With Chronic Hepatitis C

PHASE2

The objective of this trial is to investigate tolerability, safety, pharmac...

Status

Completed

Location

1241.25.002 Boehringer Ingelheim Investigational Site

Start Date

2012-02

Trial ID

NCT01528735

Treatments Being Tested

BI 207127 NA peginterferon Ribavirin Ribavirin BI 207127 NA BI 201335 NA BI 201335 NA peginterferon

Previous Next